Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016

Authors:

Abstract
Rates of opioid prescribing and deaths attributed to prescription opioid overdose have quadrupled in the United States over the past 20 years.1 One-quarter2 to one-half3 of opioid-related deaths also involve a benzodiazepine, which is consistent with the known risks of adverse events when these 2 drug classes are used concomitantly.4-7 In particular, the risk of overdose increases when people take opioids and benzodiazepines at the same time.3,4,8 Coprescribing of opioids and benzodiazepines in the United States has previously been shown to be common.8 One study9 found that, in 2013, 17% of prescription opioid users also used a benzodiazepine. Recognizing the risk of coprescribing, in 2016 the US Food and Drug Administration10 issued a warning to patients and clinicians about the potential risks of combined opioid and benzodiazepine use.